Find Technologies

  • Viral Entry or Replication Inhibitors
    •
       Ref: E-151-2006-0 | Updated: Jun 14, 2010 | NHGRI
  • Identification of Candidate Ligands which Modulate Antigen Presenting Cells
    •
       Ref: E-055-1999-0 | Updated: May 01, 2006 | NIAID
  • Method for Improved Phase Contrast MRI Resolution
    •
       Ref: E-134-2005-0 | Updated: Sep 15, 2015 | NHLBI
  • Image Guided Systems and Methods for Organ Viability Assessment
    •
       Ref: E-098-2005-0 | Updated: Jun 01, 2006 | NIDDK
  • Use of the Intracellular Signaling Domain of Receptor CD28H as a Component of Chimeric Antigen Receptors to Overcome Inhibition of Cytotoxic Lymphocytes by Checkpoint Receptors
    •    Ref: E-097-2020-0 | Updated: Sep 21, 2020 | NIAID
  • Genetic Polymorphisms Of Interleukin-1 Alpha And Beta Associated With Early Onset Periodontitis
    •
       Ref: E-076-1998-0 | Updated: Oct 01, 1998 | NIDCR
  • Signal Transduction Inhibitors Of Allergic Reactions
    •
       Ref: E-153-1997-0 | Updated: Sep 01, 1998 | NIAMS
  • Cloned Genomes Of Infectious Hepatitis C Virus And Uses Thereof
    •
       Ref: E-050-1998-0 | Updated: Jul 06, 2020 | NIAID
  • Applicator System And Method Of Use
    •
       Ref: | Updated: Aug 01, 1999 |
  • Transgenomic Viruses
    •
       Ref: E-011-1997-0 | Updated: Jun 01, 1999 | NHGRI
  • Monoclonal and Polyclonal Antibodies to 14-3-3 Proteins
    •
       Ref: | Updated: Feb 01, 1997 |
  • Virally Mediated Gene Therapy For The Control Of Chronic Or Persistent Pain
    •
       Ref: E-044-1998-0 | Updated: May 06, 2018 | NIDCR
  • Infectious Papillomavirus Pseudoviral Particles
    •
       Ref: | Updated: Dec 01, 1998 |
  • Tumor Tissue Microarrays For Rapid Molecular Profiling
    •
       Ref: E-002-1998-0 | Updated: May 16, 2016 | NHGRI
  • cDNA Sequence of a Clone Encoding Arylalkylamine N-acetyltransferase and Human Gene Encoding Serotonin N-acetyltransferase
    •
       Ref: | Updated: Dec 01, 1995 |
  • Polynucleotide Inhibition Of RNA Destabilization And Sequestration
    •
       Ref: | Updated: Feb 01, 1999 |
  • Methods For Treating Parasitic Infection Using Thiopeptides
    •
       Ref: E-202-1997-0 | Updated: May 01, 1998 | NIAID
  • Mice With A Fluorescent Marker For Interleukin-2 Gene Activation
    •
       Ref: | Updated: Dec 01, 1998 |
  • Plasmids Expressing START Domains of StAR and MLN64
    •
       Ref: | Updated: Feb 01, 2001 |
  • Hybrid Adeno-Retroviral Vector for the Transformation of Cells (E-312-2000)
    •
       Ref: E-312-2000-0 | Updated: Sep 01, 2004 | NIDCR
  • Modifications of HIV Env, Gag and Pol Enhance Immunogenicity for Genetic Immunization
    •
       Ref: E-275-2000-0 | Updated: Feb 01, 2001 | NIAID
  • Adaptive Sensitivity Encoding Incorporating Temporal Filtering (TSENSE)
    •
       Ref: E-200-2000-0 | Updated: Feb 01, 2001 | NHLBI
  • Water-Insoluble Drug Delivery System
    •
       Ref: | Updated: Jun 01, 1999 |
  • User Friendly Integrated Database for the Management of Animal Study Proposals
    •
       Ref: | Updated: May 01, 2001 |
  • Attenuated Host-Range Restricted Dengue Viruses Derived by Site-Directed Mutagenesis of the Conserved 3-Stem and Loop Structure in Genomic RNA for Use as Vaccines
    •
       Ref: E-067-1998-0 | Updated: Feb 28, 2011 |
  • A Plasmid for Expression of a More Soluble Form of HIV Integrase Protein in E. coli
    •
       Ref: | Updated: May 01, 2001 |
  • Cell Expansion System For Use In Neural Transplantation
    •
       Ref: E-235-1998-0 | Updated: Feb 01, 1999 | NINDS
  • net-Trials - Clinical Trials Information System
    •
       Ref: | Updated: Aug 01, 2001 |
  • BRB Array Tools
    •
       Ref: | Updated: Jul 01, 2001 |
  • Real Time Interactive Volumetric Magnetic Resonance Imaging
    •
       Ref: E-082-2001-0 | Updated: Jul 01, 2001 | NHLBI
  • Engineered Human Topoisomerase I
    •
       Ref: | Updated: Jul 01, 2001 |
  • Cloned Genome of Infectious Hepatitis C Virus of Genotype 2a and Uses Thereof
    •
       Ref: E-100-1999-0 | Updated: Jul 06, 2020 | NIAID
  • HCV/BVDV Chimeric Genomes and Uses Thereof
    •
       Ref: E-102-1999-0 | Updated: Jul 06, 2020 | NIAID
  • Infectious cDNA Clone of GB Virus B and Uses Thereof
    •
       Ref: E-173-1999-0 | Updated: Jul 06, 2020 | NIAID
  • Single-Chain Antibody Fragment Protein Binding to HIV-1 Integrase
    •
       Ref: | Updated: Aug 01, 2001 |
  • Generalized MRI Artifact Reduction Using Array Processing Method
    •
       Ref: E-198-2000-0 | Updated: Aug 01, 2001 | NHLBI
  • Batrachotoxins as Unique Activators of Sodium Channels
    •
       Ref: | Updated: Sep 01, 2001 |
  • NEIBANK: Microarray for Human Eye Research
    •
       Ref: | Updated: Oct 01, 2001 |
  • Recombinant Proteins of the Swine Hepatitis E Virus and Their Uses as a Vaccine and Diagnostic Reagents for Medical and Veterinary Applications
    •
       Ref: E-304-1998-0 | Updated: Jul 06, 2020 | NIAID
  • Development of Mutations Useful for Attenuating Dengue Viruses and Chimeric Dengue Viruses
    •
       Ref: E-120-2001-0 | Updated: Feb 28, 2011 | NIAID
  • Two cDNA Clones of Hepatitis E Virus (HEV) that are Infectious for Primates and Encode a Virulent and an Attenuated Virus Respectively
    •
       Ref: E-278-2001-0 | Updated: Jul 06, 2020 | NIAID
  • Novel Vectors for Identifying Transgenic and Gene Targeting Animals
    •
       Ref: | Updated: Jun 16, 2010 |
  • Four Chimpanzee Monoclonal Antibodies that Neutralize Hepatitis A Virus
    •
       Ref: E-356-2001-0 | Updated: Jul 06, 2020 | NIAID
  • N-Formyl Peptide Receptor Mediation of Platelet Chemotaxis Toward Injured Cells and Activation of Immune Response
    •
       Ref: E-282-2001-0 | Updated: Feb 01, 2002 | NIAID
  • Polyclonal Antibody to Detect Human Membrane-Bound Prostaglandin E Synthase
    •
       Ref: | Updated: Feb 01, 2002 |
  • Endotracheal Tube Using Unique Leak Hole to Lower Dead Space
    •
       Ref: E-269-2001-0 | Updated: Jun 01, 2007 | NHLBI
  • Method and Apparatus to Improve an MRI Image
    •
       Ref: E-361-2001-0 | Updated: Sep 16, 2015 | NHLBI
  • Specific Inhibition of Gene Expression by Small Double Stranded RNAs
    •
       Ref: E-284-2001-0 | Updated: May 01, 2002 |
  • Immunization for Ebola Virus Infection
    •
       Ref: E-246-2001-0 | Updated: May 01, 2002 | NIAID
  • Enhanced Distribution of Therapeutic Agents After Local Delivery
    •
       Ref: E-206-2000-0 | Updated: May 01, 2002 | NINDS
  • Use of Interferon-Inducible 2',5'-Oligoadenylate-Dependent RNase in the Diagnosis, Prognosis, and Treatment of Prostate Cancer
    •
       Ref: E-196-2001-0 | Updated: Nov 01, 2002 | NHGRI
  • Method for Convection Enhanced Delivery of Therapeutic Agents
    •
       Ref: E-202-2002-0 | Updated: May 18, 2018 | NINDS
  • Automated Centerline Detection Algorithm for Colon-Like 3D Surfaces
    •
       Ref: | Updated: Nov 01, 2002 |
  • Methods and Devices for Intramuscular Stimulation in Dysphonia
    •
       Ref: E-181-2002-0 | Updated: Mar 01, 2004 | NINDS
  • Assays for Assembly of Ebola Virus Pseudoparticles Relevant to Antiviral Therapy and Vaccines
    •
       Ref: E-090-2002-0 | Updated: Dec 01, 2002 | NIAID
  • Dengue Tetravalent Vaccine Containing a Common 30 Nucleotide Deletion in the 3'-UTR of Dengue Types 1, 2, 3, and 4
    •
       Ref: E-089-2002-1 | Updated: May 06, 2016 | NIAID
  • Fibroblast Growth Factor 3 (FGFR3) Receptor Knockin Mice
    •
       Ref: E-060-2003-0 | Updated: May 14, 2018 | NIDDK
  • Recombinant SUMO-1 Isopeptidase Substrates for FRET Assays
    •
       Ref: | Updated: Feb 01, 2003 |
  • Methods of Screening for Risk of Cancer Using Human Lactoferrin DNA Probe or Primer
    •
       Ref: E-003-1991-0 | Updated: Mar 01, 2003 |
  • Tissue Microarray For Rapid Molecular Profiling
    •
       Ref: E-007-1999-0 | Updated: Jan 01, 1999 | NHGRI
  • Compositions and Methods for Inhibiting Vascular Channels and Methods of Inhibiting Proliferation
    •
       Ref: E-320-2001-0 | Updated: Jun 01, 2005 | NIDCR
  • HTLV-1 Cell Binding and Inhibition
    •
       Ref: E-240-2002-0 | Updated: May 01, 2003 | NIAID
  • Mouse Monoclonal Antibodies Against Human IKKgamma/NEMO Protein
    •
       Ref: E-118-2003-0 | Updated: Jun 01, 2003 | NIAID
  • Oral Treatment of Hemophilia
    •
       Ref: E-281-2001-0 | Updated: Dec 04, 2013 | NIAID
  • Recombinant Plasmids for Soluble Immunoreceptors
    •
       Ref: E-305-2003-0 | Updated: Oct 01, 2003 | NIAID
  • Methods and Materials for Controlling Stem Cell and Cancer Cell Proliferation and Differentiation
    •
       Ref: E-001-2003-0 | Updated: Oct 01, 2003 | NINDS
  • Peptide Mimotope Candidates for Otitis Media Vaccine
    •
       Ref: E-344-2002-0 | Updated: Jun 16, 2010 | NIDCD
  • Combination Cancer Therapy with HDAC Inhibitors
    •
       Ref: E-065-2016 | Updated: Apr 03, 2018 | NCI
  • Bioluminescent Bladder Cancer Cell Line for Tracking Cancer Progression
    •    Ref: E-237-2018 | Updated: Nov 08, 2018 | NCI
  • Optical Microscope Software for Breast Cancer Diagnosis
    •
       Ref: E-286-2012 | Updated: Sep 30, 2016 | NCI
  • MADCO-Accelerated Multidimensional Diffusion MRI
    •
       Ref: E-173-2016 | Updated: Dec 07, 2017 | NICHD
  • Treatment of Oculocutaneous/Ocular Albinism and for Increasing Pigmentation
    •
       Ref: E-113-2010 | Updated: May 10, 2019 | NEI
  • Modulating Chemotherapeutic Cytotoxicity
    •
       Ref: E-296-2011 | Updated: Sep 06, 2016 | NCI
  • Use of Anti-CD47 Antibodies for the Treatment of Cancer
    •
       Ref: E-263-2014 | Updated: Aug 31, 2016 | NCI
  • Method for Generating Pluripotent and Multipotent Cells
    •
       Ref: E-086-2012 | Updated: Apr 17, 2018 | NCI
  • Novel Fixative for Improved Biomolecule Quality from Paraffin-Embedded Tissue
    •
       Ref: E-139-2015 | Updated: Jul 19, 2018 | NCI
  • Module to Freeze and Store Frozen Tissue
    •
       Ref: E-173-2015 | Updated: Aug 03, 2017 | NCI
  • Platform to Enhance Anti-Tumor Immunity
    •
       Ref: E-053-2019 | Updated: Sep 22, 2020 | NCI
  • Automated Cancer Diagnostic Tool of Detecting, Quantifying and Mapping Mitotically-Active Proliferative Cells in Tumor Tissue Histopathology Whole-Slide Images
    •
       Ref: E-038-2019 | Updated: Jun 17, 2020 | NCI
  • Cancer Therapeutic Based on T Cell Receptors Designed to Regiospecifically Release Interleukin-12
    •
       Ref: E-170-2009 | Updated: Aug 31, 2016 | NCI
  • Human T Cell Receptors for Treating Cancer
    •
       Ref: E-269-2010 | Updated: May 04, 2018 | NCI
  • A Dendritic Cell Vaccine to Immunize Cancer Patients Against Mutated Neoantigens Expressed by the Autologous Cancer
    •
       Ref: E-280-2016 | Updated: Aug 15, 2018 | NCI
  • A Method to Isolate Tumor Specific T-Cells or T-Cell Receptors from Peripheral Blood using In-vitro Stimulation of Memory T-Cells
    •
       Ref: E-238-2017 | Updated: Jun 28, 2019 | NCI
  • T Cell Receptors (TCRs) Specific for Mutant p53
    •
       Ref: E-135-2019 | Updated: Sep 03, 2020 | NCI
  • Nitric Oxide-Releasing Polymers for Wound Healing
    •
       Ref: E-157-2012 | Updated: Sep 05, 2016 | NCI
  • Methods for Selection of Cancer Patients and Predicting Efficacy of Combination Therapy
    •
       Ref: E-013-2012 | Updated: Mar 06, 2017 | NCI
  • Use of a Modified Adaptor Molecule LAT to Improve Immunotherapy for Cancer and Other Diseases
    •
       Ref: E-159-2009 | Updated: Oct 10, 2017 | NCI
  • Small Molecule Anti-cancer Agents that Stabilize the MYC-G-Quadruplex
    •
       Ref: E-053-2015 | Updated: Apr 03, 2018 | NCI
  • Schweinfurthins and Uses Thereof
    •
       Ref: E-183-2009 | Updated: Mar 20, 2018 | NCI
  • Chimeric Adaptor Proteins (CAPs) Containing a Linker for Activation of T Cells (LAT) and a Kinase Domain for Use in T Cell-Based Immunotherapy
    •
       Ref: E-210-2018 | Updated: May 19, 2020 | NCI
  • RP2 and RPGR Vectors For Treating X-linked Retinitis Pigmentosa
    •
       Ref: E-050-2015 | Updated: Jun 01, 2018 | NEI
  • Detection of Novel Endocrine-Disrupting Chemicals in Water Supplies
    •
       Ref: E-269-2011 | Updated: Sep 16, 2020 | NCI
  • Anti-Viral Compounds that Inhibit HIV Activity
    •
       Ref: E-081-2011 | Updated: Apr 20, 2018 | NCI
  • Use of the TP5 Peptide for the Treatment of Cancer
    •
       Ref: E-007-2019 | Updated: Oct 06, 2020 | NCI
  • A Novel Genetically Encoded Inhibitor of Hippo Signaling Pathway to Study YAP1/TAZ-TEAD Dependent Events in Cancer
    •
       Ref: E-108-2019 | Updated: Apr 02, 2020 | NCI
  • Peptide Hydrogels for Rate-Controlled Delivery of Therapeutics
    •
       Ref: E-188-2017 | Updated: Apr 20, 2020 | NCI
  • Reporter Assay for Detection and Quantitation of Replication-Competent Gammaretrovirus
    •
       Ref: E-125-2020 | Updated: Jul 07, 2020 | NCI
  • A peptide hydrogel for use in vascular anastomosis
    •
       Ref: E-292-2014 | Updated: Nov 27, 2019 |
  • Nanoparticle-hydrogel Composite for Nucleic Acid Molecule Delivery
    •
       Ref: E-080-2018 | Updated: May 14, 2019 | NCI
  • Video Monitoring and Analysis System for Vivarium Cage Racks
    •
       Ref: E-090-2013 | Updated: Jul 19, 2018 | NCI

    Pages


    Displaying 1001 - 1100 of 1368

    Category Index

    Office of Technology Transfer, Office of Intramural Research, National Institutes of Health

    6011 Executive Blvd, Suite 325, Rockville, MD 20852 | Phone: 301-496-7057